Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000
4061.T Stock Summary
Top 10 Correlated ETFs
4061.T
In the News
4061.T Financial details
Company Rating
Buy
Market Cap
213.07B
Income
7.51B
Revenue
391.67B
Book val./share
3562
Cash/share
362.77
Dividend
90
Dividend %
3.48%
Employees
6.41K
Optionable
No
Shortable
Yes
Earnings
09 May 2024
P/E
44.58
Forward P/E
14.82
PEG
-6.27
P/S
0.56
P/B
0.71
P/C
6.47
P/FCF
-
Quick Ratio
0.68
Current Ratio
1.41
Debt / Equity
0.66
LT Debt / Equity
0.35
-
-
EPS (TTM)
87.09
EPS next Y
158.42
EPS next Q
101.68
EPS this Y
-50.91%
EPS next Y
81.91%
EPS next 5Y
227.02%
EPS last 5Y
-12.35%
Revenue last 5Y
-0.27%
Revenue Q/Q
-2%
EPS Q/Q
-169.84%
-
-
-
-
SMA20
-3.13%
SMA50
-5.75%
SMA100
-10.33%
Inst Own
-
Inst Trans
-
ROA
1%
ROE
2%
ROC
0.06%
Gross Margin
23%
Oper. Margin
6%
Profit Margin
1%
Payout
-
Shs Outstand
89.33M
Shs Float
75.84M
-
-
-
-
Target Price
-
52W Range
2362.0-2909.0
52W High
-19.3%
52W Low
-0.61%
RSI
34.45
Rel Volume
1.81
Avg Volume
430.69K
Volume
778.4K
Perf Week
-3.77%
Perf Month
-5.72%
Perf Quarter
-13.15%
Perf Half Y
-17.21%
-
-
-
-
Beta
0.506
-
-
Volatility
47.21%, 49.56%
Prev Close
-0.32%
Price
2347.5
Change
-2.11%
4061.T Financial Performance
Yearly Fundamentals Overview
Last date of statement is 2023-03-31
Metric | History | 2019-03-31 | 2020-03-31 | 2021-03-31 | 2022-03-31 | 2023-03-31 |
---|---|---|---|---|---|---|
2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
Revenue per share | 4.72K | 4.4K | 4.11K | 4.46K | 4.73K | |
Net income per share | 286.18 | 262.62 | 264.23 | 301.67 | 148.07 | |
Operating cash flow per share | 373.18 | 485.31 | 470.95 | 494.39 | 103.75 | |
Free cash flow per share | 59.44 | 93.87 | 36.14 | 54.23 | -358.27 | |
Cash per share | 113.1 | 281.54 | 251.67 | 189.15 | 170.83 | |
Book value per share | 2.82K | 2.9K | 3.1K | 3.35K | 3.44K | |
Tangible book value per share | 2.72K | 2.8K | 3K | 3.27K | 3.36K | |
Share holders equity per share | 2.82K | 2.9K | 3.1K | 3.35K | 3.44K | |
Interest debt per share | 1.29K | 1.56K | 1.61K | 1.6K | 1.98K | |
Market cap | 287.06B | 196.84B | 381.14B | 293.18B | 235.84B | |
Enterprise value | 385.29B | 302.01B | 493.42B | 410B | 385.37B | |
P/E ratio | 11.46 | 8.67 | 16.73 | 11.27 | 18.47 | |
Price to sales ratio | 0.69 | 0.52 | 1.08 | 0.76 | 0.58 | |
POCF ratio | 8.79 | 4.69 | 9.39 | 6.88 | 26.36 | |
PFCF ratio | 55.18 | 24.26 | 122.32 | 62.7 | -7.63 | |
P/B Ratio | 1.16 | 0.79 | 1.43 | 1.02 | 0.8 | |
PTB ratio | 1.16 | 0.79 | 1.43 | 1.02 | 0.8 | |
EV to sales | 0.93 | 0.79 | 1.39 | 1.07 | 0.95 | |
Enterprise value over EBITDA | 6.64 | 5.54 | 8.48 | 6.4 | 6.5 | |
EV to operating cash flow | 11.8 | 7.2 | 12.15 | 9.62 | 43.08 | |
EV to free cash flow | 74.07 | 37.22 | 158.35 | 87.68 | -12.47 | |
Earnings yield | 0.09 | 0.12 | 0.06 | 0.09 | 0.05 | |
Free cash flow yield | 0.02 | 0.04 | 0.01 | 0.02 | -0.13 | |
Debt to equity | 0.45 | 0.54 | 0.52 | 0.48 | 0.57 | |
Debt to assets | 0.23 | 0.27 | 0.26 | 0.25 | 0.29 | |
Net debt to EBITDA | 1.69 | 1.93 | 1.93 | 1.82 | 2.52 | |
Current ratio | 1.24 | 1.23 | 1.29 | 1.31 | 1.53 | |
Interest coverage | 44.92 | 36.47 | 42.3 | 43.42 | 27.94 | |
Income quality | 1.01 | 1.45 | 1.4 | 1.23 | 0.61 | |
Dividend Yield | 0.04 | 0.05 | 0.03 | 0.04 | 0.05 | |
Payout ratio | 0.4 | 0.46 | 0.47 | 0.45 | 0.98 | |
Sales general and administrative to revenue | 0.08 | 0.09 | 0.09 | 0.09 | 0.09 | |
Research and developement to revenue | 0.04 | 0.04 | 0.04 | 0.04 | 0.04 | |
Intangibles to total assets | 0.03 | 0.02 | 0.02 | 0.02 | 0.02 | |
Capex to operating cash flow | -0.84 | -0.81 | -0.92 | -0.89 | -4.45 | |
Capex to revenue | -0.07 | -0.09 | -0.11 | -0.1 | -0.1 | |
Capex to depreciation | -1.2 | -1.51 | -1.64 | -1.59 | -1.47 | |
Stock based compensation to revenue | 0 | 0 | 0 | 0 | 0 | |
Graham number | 4.26K | 4.14K | 4.29K | 4.77K | 3.38K | |
ROIC | 0.07 | 0.06 | 0.06 | 0.07 | 0.06 | |
Return on tangible assets | 0.05 | 0.05 | 0.04 | 0.05 | 0.02 | |
Graham Net | -1.32K | -1.4K | -1.49K | -1.52K | -1.66K | |
Working capital | 36.68B | 37.65B | 45.66B | 51.49B | 87.34B | |
Tangible asset value | 238.07B | 242.21B | 258.65B | 281.7B | 289.35B | |
Net current asset value | -42.61B | -48.98B | -55.27B | -47.39B | -40.01B | |
Invested capital | 0.45 | 0.54 | 0.52 | 0.48 | 0.57 | |
Average receivables | 96.85B | 90.71B | 89.23B | 96.92B | 99.55B | |
Average payables | 53.27B | 47.96B | 41.6B | 45.11B | 49B | |
Average inventory | 69.03B | 73.77B | 73.75B | 78.69B | 103.39B | |
Days sales outstanding | 84.62 | 82.08 | 95.59 | 95.82 | 87.84 | |
Days payables outstanding | 62.15 | 55.77 | 57.71 | 65.77 | 57.36 | |
Days of inventory on hand | 84.26 | 98.27 | 102.97 | 112.6 | 144.85 | |
Receivables turnover | 4.31 | 4.45 | 3.82 | 3.81 | 4.16 | |
Payables turnover | 5.87 | 6.54 | 6.33 | 5.55 | 6.36 | |
Inventory turnover | 4.33 | 3.71 | 3.54 | 3.24 | 2.52 | |
ROE | 0.1 | 0.09 | 0.09 | 0.09 | 0.04 | |
Capex per share | -313.74 | -391.43 | -434.81 | -440.16 | -462.02 |
Quarterly Fundamentals Overview
Last date of statement is 2023-12-31 for Q3
Metric | History | 2022-12-31 | 2023-03-31 | 2023-06-30 | 2023-09-30 | 2023-12-31 |
---|---|---|---|---|---|---|
2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
Revenue per share | 1.23K | 1.15K | 1.02K | 1.2K | 1.18K | |
Net income per share | -63.61 | 45.53 | 26.62 | 49.47 | -34.55 | |
Operating cash flow per share | 157.53 | 159.67 | 155.1 | 156.18 | 156.22 | |
Free cash flow per share | 157.53 | 159.67 | 155.1 | 156.18 | 156.22 | |
Cash per share | 256.52 | 232.89 | 197.56 | 235.53 | 362.77 | |
Book value per share | 3.48K | 3.44K | 3.49K | 3.63K | 3.56K | |
Tangible book value per share | 3.39K | 3.36K | 3.41K | 3.54K | 3.58K | |
Share holders equity per share | 3.48K | 3.44K | 3.49K | 3.63K | 3.56K | |
Interest debt per share | 2.07K | 1.97K | 2.13K | 2.22K | 2.37K | |
Market cap | 260.85B | 235.84B | 233.89B | 232.98B | 215.1B | |
Enterprise value | 416.99B | 385.37B | 395.11B | 403.82B | 387.43B | |
P/E ratio | -11.89 | 15.02 | 25.48 | 13.66 | -18.06 | |
Price to sales ratio | 2.47 | 2.39 | 2.66 | 2.25 | 2.12 | |
POCF ratio | 19.2 | 17.13 | 17.49 | 17.31 | 15.98 | |
PFCF ratio | 19.2 | 17.13 | 17.49 | 17.31 | 15.98 | |
P/B Ratio | 0.87 | 0.8 | 0.78 | 0.75 | 0.7 | |
PTB ratio | 0.87 | 0.8 | 0.78 | 0.75 | 0.7 | |
EV to sales | 3.94 | 3.9 | 4.5 | 3.9 | 3.82 | |
Enterprise value over EBITDA | 54.42 | 75.28 | 126.8 | 60.43 | 285.71 | |
EV to operating cash flow | 30.7 | 27.99 | 29.54 | 30 | 28.78 | |
EV to free cash flow | 30.7 | 27.99 | 29.54 | 30 | 28.78 | |
Earnings yield | -0.02 | 0.02 | 0.01 | 0.02 | -0.01 | |
Free cash flow yield | 0.05 | 0.06 | 0.06 | 0.06 | 0.06 | |
Debt to equity | 0.59 | 0.57 | 0.61 | 0.61 | 0.66 | |
Debt to assets | 0.29 | 0.29 | 0.3 | 0.3 | 0.32 | |
Net debt to EBITDA | 20.38 | 29.21 | 51.74 | 25.57 | 127.09 | |
Current ratio | 1.47 | 1.53 | 1.5 | 1.41 | 1.47 | |
Interest coverage | 19.93 | 22.61 | 7.38 | 19.16 | 4.78 | |
Income quality | -2.48 | 3.51 | 5.83 | 3.16 | -4.52 | |
Dividend Yield | 0 | 0 | 0 | 0 | 0 | |
Payout ratio | 0 | 0 | 0 | 0 | 0 | |
Sales general and administrative to revenue | 0 | -0.08 | 0 | 0 | 0 | |
Research and developement to revenue | 0.04 | 0.04 | 0.04 | 0.04 | 0.04 | |
Intangibles to total assets | 0.02 | 0.02 | 0.02 | 0.02 | 0.01 | |
Capex to operating cash flow | 0 | 0 | 0 | 0 | 0 | |
Capex to revenue | 0 | 0 | 0 | 0 | 0 | |
Capex to depreciation | 0 | 0 | 0 | 0 | 0 | |
Stock based compensation to revenue | 0 | 0 | 0 | 0 | 0 | |
Graham number | 2.23K | 1.88K | 1.45K | 2.01K | 1.66K | |
ROIC | 0.01 | 0.01 | 0 | 0.01 | 0 | |
Return on tangible assets | -0.01 | 0.01 | 0 | 0.01 | 0 | |
Graham Net | -1.61K | -1.6K | -1.73K | -1.64K | -1.65K | |
Working capital | 88.02B | 87.34B | 87.18B | 79.97B | 90.37B | |
Tangible asset value | 292.49B | 289.35B | 293.73B | 305.02B | 308.91B | |
Net current asset value | -37.16B | -40.01B | -40.58B | -36.31B | -40.32B | |
Invested capital | 0.59 | 0.57 | 0.61 | 0.61 | 0.66 | |
Average receivables | 118.17B | 110.84B | 97.21B | 104.06B | 114.07B | |
Average payables | 60.88B | 55.96B | 49.08B | 49.88B | 51.34B | |
Average inventory | 116.6B | 120.3B | 126.27B | 131.12B | 127.61B | |
Days sales outstanding | 105.14 | 89.32 | 98.71 | 97.17 | 103.19 | |
Days payables outstanding | 71.5 | 56.94 | 66.4 | 56.58 | 57.82 | |
Days of inventory on hand | 133.58 | 143.77 | 173.84 | 149.33 | 135.42 | |
Receivables turnover | 0.86 | 1.01 | 0.91 | 0.93 | 0.87 | |
Payables turnover | 1.26 | 1.58 | 1.36 | 1.59 | 1.56 | |
Inventory turnover | 0.67 | 0.63 | 0.52 | 0.6 | 0.66 | |
ROE | -0.02 | 0.01 | 0.01 | 0.01 | -0.01 | |
Capex per share | 0 | 0 | 0 | 0 | 0 |
4061.T Frequently Asked Questions
What is Denka Company Limited stock symbol ?
Denka Company Limited is a JP stock and trading under the symbol 4061.T
What is Denka Company Limited stock quote today ?
Denka Company Limited stock price is $2347.5 today.
Is Denka Company Limited stock public?
Yes, Denka Company Limited is a publicly traded company.